Calyx Bio-Ventures Inc. (TSXV:CYX) announced a non-brokered private placement of 9,285,713 units at CAD 0.07 per unit for gross proceeds of CAD 650,000 on June 20, 2018. Each unit consists of one common share and one half of one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at a price of CAD 0.15 per share for a period of 12 months, subject to accelerated expiry in the event the closing price of the company's common shares is CAD 0.20 or higher for ten consecutive trading days. The securities issued are subject to a hold period of four months plus one day statutory hold period. The transaction is subject to TSX Venture Exchange approval.